通过药物基因组学改善乳腺癌治疗:叙事性综述
Ram Mohan Ram Kumar1, Suresh Joghee2
1Department of Pharmaceutical Biotechnology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India.
概括
药物基因组学使用遗传洞察来个性化乳腺癌治疗,通过量身定制药物选择和剂量来改善结果. 进一步的研究和将其纳入临床实践是最大限度地提高效益和最大限度地减少副作用的关键.
科学领域:
- 在瘤学瘤学.
- 药物基因组学 药物基因组学
- 个性化医疗是个性化的医疗.
背景情况:
- 药物基因组学对于个性化乳腺癌药物至关重要,指导基于遗传变异的治疗选择和剂量.
- 遗传多态性影响药物代谢,反应和毒性,影响各种乳腺癌疗法的疗效和安全性.
- 激素受体状态和突变的生物标志物是确定治疗反应的关键.
研究的目的:
- 审查药物基因组学在乳腺癌治疗中的整合.
- 突出遗传影响对治疗反应和毒性的重要性.
- 讨论先进技术在完善乳腺癌治疗策略方面的潜力.
主要方法:
- 对乳腺癌中药物基因组学现有文献的综述.
- 讨论药物代谢酶和转运体中的遗传多态性.
- 探索全基因组关联研究和先进的测序技术.
主要成果:
- 遗传变异在乳腺癌治疗中显著影响药物的疗效和安全性.
- 需要新的遗传标记物和精细的治疗优化策略.
- 像GWAS和测序等先进技术有望揭示药物反应的遗传决定因素.
结论:
- 药物基因组学使量身定制的乳腺癌治疗成为可能,最大限度地提高益处,最大限度地减少不良影响.
- 实时监测,新的预测标志物和临床整合是未来的方向.
- 合作努力是必要的,以克服实施挑战,并确保公平获得基因测试.
更多相关视频
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


